| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in ARWR over the last quarter tilts toward selling: insiders offloaded a net 13,600 shares worth roughly $1.2M.
Counted by filing, the last 12 months brought no open-market purchases and 19 sales by 10 insiders worth about $37.3M. The 12 months before that brought no open-market purchases and 18 sales by 8 insiders worth about $13.2M.
13 of the 19 sales in the last 12 months were made under a Rule 10b5-1 trading plan; the rest were not.
No insider has bought ARWR shares in the open market in the last two years. The last purchase on record was by Hongbo Lu on March 20, 2024.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $225.78M | - | |
| COO | 547.4K | $32.59M | - | |
| Other | 227.0K | $13.51M | - | |
| CFO | 162.9K | $9.70M | - | |
| Dir | 111.5K | $6.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Adeoye Y Olukotun52 | Director | Sell | 2,000 | $86.96 | $173,920.00 | -6.0% | - | - | |
| Aug 18, 2026 | Michael S Perry55 | Director | Sell | 11,600 | $87.30 | $1,012,680.00 | -9.4% | - | - | |
| May 12, 2026 | Hongbo Lu61 | Director | Sell10b5-1 | 2,970 | $76.88 | $228,333.60 | -5.4% | +11.8% | - | |
| Apr 23, 2026 | James C Hamilton58 | Chief Medical Officer | Sell10b5-1 | 10,000 | $75.00 | $750,000.00 | -4.2% | +19.2% | - | |
| Apr 22, 2026 | Daniel Joseph Apel | Chief Financial Officer | Sell10b5-1 | 13,095 | $71.35 | $934,285.13 | -7.4% | +0.8% | - | |
| Mar 5, 2026 | James C Hamilton58 | Chief Medical Officer | Sell10b5-1 | 10,000 | $64.19 | $641,900.00 | -4.0% | +14.1% | - | |
| Jan 5, 2026 | James C Hamilton58 | Chief Medical Officer | Sell10b5-1 | 40,164 | $63.11 | $2,534,661.46 | -18.9% | -4.3% | - | |
| Jan 5, 2026 | Patrick O'Brien76 | COO | Sell10b5-1 | 49,493 | $63.11 | $3,123,349.43 | -9.4% | -4.3% | - | |
| Jan 2, 2026 | Christopher Richard Anzalone60 | Chief Executive Officer | Sell10b5-1 | 13,187 | $66.10 | $871,702.77 | -0.3% | -10.0% | - | |
| Dec 29, 2025 | Christopher Richard Anzalone60 | Chief Executive Officer | Sale+OE10b5-1 | 51,726 | $69.13 | $3,575,574.78 | -1.3% | -17.2% | - |